IM Cannabis PEG Ratio

IM Cannabis's peg ratio stands at 101.33. That is above the Healthcare sector average of 1.26. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

IM Cannabis sits higher the Healthcare benchmark (1.26) with a PEG ratio of 101.33. That is roughly 7959.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 101.33 is attractive depends on IM Cannabis's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how IM Cannabis's PEG ratio evolved across reporting periods, while the comparison chart places IMCC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. IM Cannabis's reading of 101.33 (sector avg 1.26) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.